Table of Contents
How long do hepatitis E symptoms last?
There is no specific treatment for hepatitis E infection lasting less than six months (acute). It is regarded as a self-limiting disease, meaning that it runs a defined or limited course. Most people who have hepatitis E will go on to recover completely within four weeks from the start of their symptoms.
How does hepatitis E affect the body?
Hepatitis E is a virus that infects your liver. It can cause your liver to swell up. Most people with hepatitis E get better within a few months. Usually it doesn’t lead to long-term illness or liver damage like some other forms of hepatitis do.
How do you know your hepatitis is chronic?
People who test positive for the hepatitis B virus for more than six months (after their first blood test result) are diagnosed as having a chronic infection. This means their immune system was not able to get rid of the hepatitis B virus and it still remains in their blood and liver.
Can chronic hepatitis E be cured?
Hepatitis E usually resolves on its own without treatment. There is no specific antiviral therapy for acute hepatitis E. Physicians should offer supportive therapy.
Is Hep E chronic?
Hepatitis E is an acute or chronic infection with the hepatitis E virus (HEV). In Europe, most of the infections are locally-acquired and asymptomatic. Acute infections cause a self-limiting hepatitis, but can become chronic in immuno-compromised patients with the risk of the development of severe liver cirrhosis.
Is Hepatitis E Serious?
How serious is hepatitis E? Most people with hepatitis E recover completely. During hepatitis E outbreaks, the overall case-fatality rate is about 1\% (10). However, for pregnant women, hepatitis E can be a serious illness, with mortality reaching 10\%–30\% among pregnant women in their third trimester (11).
Does hepatitis E cause chronic hepatitis?
It is now well accepted that hepatitis E virus (HEV) infection can induce chronic hepatitis and cirrhosis in immunosuppressed patients. Chronic genotype-3 HEV infections were first reported in patients with a solid-organ transplant.